Category

• Pipeline1
• Research1

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• Cornea2
• Corneal Transplant2
• Clinical Trials1
• Keratopathy1

• Organizations: Cellusion Inc.✕

Clear all

Pipeline

Cellusion receives ODD for bullous keratopathy regenerative compound

Corneal cell therapy is designed as an alternative solution for corneal transplantations.

Research

First patient transplanted with iPSC-derived CE cell substitute

Cellusion Inc.’s first-in-human study is assessing CLS001 transplantation in patients with regrafted cases of bullous keratopathy.